Skip to main content

Table 2 Clinical and laboratory characteristics

From: Relationship between BDNF gene polymorphisms and alcohol-related liver cirrhosis

Parameter

AUD, n = 71

ALC, n = 110

p value

Platelet count, ƗĀ 109/L

216.5 (169.0; 251)

164.5 (113.5; 243.5)

p = 0.003

ALT, U/L

27.9 (21.7; 43.3)

24.1 (15.8; 39.0)

p = 0.012

AST, U/L

46.1 (28.1; 62.6)

56.1 (33.2; 108.7)

p = 0.017

AST/ALT ratio

1.4 (1.1; 1.7)

2.8 (2.6; 1.5)

p = 8.613Ā Ć—Ā 10-12

GGT, U/L

46.6 (36.1; 71.3)

197.5 (80.0; 302.0)

p = 6.879Ā Ć—Ā 10āˆ’10

ALP, U/L

178.0 (144.0; 213.5)

137.0 (95.0; 197.0)

p = 3.556Ā Ć—Ā 10āˆ’4

Total bilirubin, Ī¼mol/L

13.3 (10.7; 19.2)

50.8 (26.4; 152.1)

p = 2.559Ā Ć—Ā 10āˆ’17

Childā€“Pugh class

ā€ƒA

0

17

ā€“

ā€ƒB

0

24

ā€ƒC

0

69

Encephalopathy:

ā€ƒYes

7

53

Ļ‡2 = 26.893; p <

ā€ƒNo

64

57

0.001

Type II diabetes mellitus:

ā€ƒYes

1

21

Ļ‡2 = 11.034; p =

ā€ƒNo

70

89

0.001

  1. Continuous variables are shown as median (lower quartile; upper quartile). Mannā€“Whitney U test was performed for pairwise comparisons of continuous variables between the AUD and ALC groups. Chi-square test was used to compare categorical variables between the groups
  2. Abbreviations: AUDĀ alcohol use disorder, ALCĀ alcohol-related liver cirrhosis, ALTĀ alanine aminotransferase,Ā ASTĀ aspartate aminotransferase, ALPĀ alkaline phosphatase, GGTĀ Ī³-glutamyl transferase